Search research articles
Contact Us
Filters
Showing results (11-20 of 110) with videos related to
Page
of 11
Sort By:
Journal of the National Cancer Institute
|
January 1, 1997
Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations
D R Budman, L Weiselberg, V O'Mara
Leukemia
|
October 6, 2001
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?
D R Budman, A Calabro, W Kreis
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents
W Kreis, D R Budman, A Calabro
Journal of Clinical Gastroenterology
|
August 1, 1987
High grade dysplasia in Crohn's colitis characterized by flow cytometry
M J McKinley, D R Budman, E Kahn
New York State Journal of Medicine
|
October 1, 1985
Erythroleukemia in the adjuvant treatment of breast cancer
S M Lichtman, P Schulman, D R Budman
Breast Cancer Research and Treatment
|
May 30, 2009
The hedgehog pathway as a therapeutic target for treatment of breast cancer
M F Barginear, M Leung, D R Budman
European Journal of Cancer
|
April 1, 1978
The current causes of death in patients with malignant melanoma
D R Budman, E Camacho, R E Wittes
Journal of the American Academy of Dermatology
|
May 1, 1988
Cyclosporin a (cyclosporine) in the treatment of cutaneous T cell lymphoma (mycosis fungoides)
W Kreis, D R Budman, P E Shapiro
Cancer Treatment Reports
|
May 1, 1981
Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma
D R Budman, P Schulman, V Vinciguerra, et al.
American Journal of Clinical Pathology
|
June 1, 1981
The diagnostic value of the serum lactic dehydrogenase determination in the evaluation of unexplained thrombocytosis
D R Budman, H Lackner, P Berczeller, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 110) with videos related to
Sort By:
Page
of 11
Journal of the National Cancer Institute
|
January 1, 1997
Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations
D R Budman, L Weiselberg, V O'Mara
Leukemia
|
October 6, 2001
In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?
D R Budman, A Calabro, W Kreis
Cancer Chemotherapy and Pharmacology
|
February 28, 2001
A reexamination of PSC 833 (Valspodar) as a cytotoxic agent and in combination with anticancer agents
W Kreis, D R Budman, A Calabro
Journal of Clinical Gastroenterology
|
August 1, 1987
High grade dysplasia in Crohn's colitis characterized by flow cytometry
M J McKinley, D R Budman, E Kahn
New York State Journal of Medicine
|
October 1, 1985
Erythroleukemia in the adjuvant treatment of breast cancer
S M Lichtman, P Schulman, D R Budman
Breast Cancer Research and Treatment
|
May 30, 2009
The hedgehog pathway as a therapeutic target for treatment of breast cancer
M F Barginear, M Leung, D R Budman
European Journal of Cancer
|
April 1, 1978
The current causes of death in patients with malignant melanoma
D R Budman, E Camacho, R E Wittes
Journal of the American Academy of Dermatology
|
May 1, 1988
Cyclosporin a (cyclosporine) in the treatment of cutaneous T cell lymphoma (mycosis fungoides)
W Kreis, D R Budman, P E Shapiro
Cancer Treatment Reports
|
May 1, 1981
Phase II trial: mitomycin c and methotrexate combination therapy for advanced colorectal carcinoma
D R Budman, P Schulman, V Vinciguerra, et al.
American Journal of Clinical Pathology
|
June 1, 1981
The diagnostic value of the serum lactic dehydrogenase determination in the evaluation of unexplained thrombocytosis
D R Budman, H Lackner, P Berczeller, et al.
Page
of 11